Influence of Perineural Invasion on Survival and Recurrence in Patients with Resected Pancreatic Cancer |
Zhang, Jun-Feng
(Department of General Surgery, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University)
Hua, Rong (Department of General Surgery, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University) Sun, Yong-Wei (Department of General Surgery, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University) Liu, Wei (Department of General Surgery, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University) Huo, Yan-Miao (Department of General Surgery, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University) Liu, De-Jun (Department of General Surgery, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University) Li, Jiao (Department of General Surgery, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University) |
1 | Bachellier P, Rosso E, Lucescu I, et al (2011). Is the need for an arterial resection a contraindication to pancreatic resection for locally advanced pancreatic adenocarcinoma? A casematched controlled study. J Surg Oncol, 103, 75-84. DOI ScienceOn |
2 | Balentine CJ, Enriquez J, Fisher W, et al (2010). Intra-abdominal fat predicts survival in pancreatic cancer. J Gastrointest Surg, 14, 1832-7. DOI |
3 | Boyd CA, Benarroch-Gampel J, Sheffield KM, Cooksley CD, Riall TS (2012) 415 patients with adenosquamous carcinoma of the pancreas: a population-based analysis of prognosis and survival. J Surg Res, 174, 12-9. DOI ScienceOn |
4 | Bapat AA, Hostetter G, Von Hoff DD, Han H (2011). Perineural invasion and associated pain in pancreatic cancer. Nat Rev Cancer, 11, 695-707. DOI ScienceOn |
5 | Barbier L, Turrini O, Gregoire E, et al (2011). Pancreatic head resectable adenocarcinoma: preoperative chemoradiation improves local control but does not affect survival. HPB (Oxford), 13, 64-9. DOI ScienceOn |
6 | Ben QW, Wang JC, Liu J, et al (2010). Positive expression of L1-CAM is associated with perineural invasion and poor outcome in pancreatic ductal adenocarcinoma. Ann Surg Oncol, 17, 2213-21. DOI |
7 | Ceyhan GO, Schafer KH, Kerscher AG, et al (2010). Nerve growth factor and artemin are paracrine mediators of pancreatic neuropathy in pancreaticadenocarcinoma. Ann Surg, 251, 923-31. DOI ScienceOn |
8 | Chatterjee D, Katz MH, Rashid A, et al (2012). Perineural and intraneural invasion in posttherapy pancreaticoduodenectomy specimens predicts poor prognosis in patients with pancreatic ductal adenocarcinoma. Am J Surg Pathol, 36, 409-17. DOI |
9 | Cheng P, Jin G, Hu X, et al (2012). Analysis of tumorinduced lymphangiogenesis and lymphatic vessel invasion ofpancreatic carcinoma in the peripheral nerve plexus. Cancer Sci, 103, 1756-63. DOI ScienceOn |
10 | Chu CK, Mazo AE, Goodman M, et al (2010). Preoperative diabetes mellitus and long-term survival after resection of pancreatic adenocarcinoma. Ann Surg Oncol, 17, 502-13. DOI |
11 | Fisher SB, Patel SH, Bagci P, et al (2013). An analysis of human equilibrative nucleoside transporter-1, ribonucleoside reductase subunit M1, ribonucleoside reductase subunit M2, and excision repair cross-complementing gene-1 expression in patients with resected pancreas adenocarcinoma: implications for adjuvant treatment. Cancer, 119, 445-53. DOI ScienceOn |
12 | de Jong MC, Li F, Cameron JL, et al (2011). Re-evaluating the impact of tumor size on survival following pancreaticoduodenectomy for pancreatic adenocarcinoma. J Surg Oncol, 103, 656-62. DOI ScienceOn |
13 | Gebhardt C, Meyer W, Reichel M, Wünsch PH (2000). Prognostic factors in the operative treatment of ductal pancreatic carcinoma. Langenbecks Arch Surg, 385, 14-20. DOI |
14 | Farnell MB, Pearson RK, Sarr MG, et al (2005). A prospective randomized trial comparing standard pancreatoduodenectomy with pancreatoduodenectomy with extended lymphadenectomy in resectable pancreatic head adenocarcinoma. Surgery, 138, 618-28; discussion 628-30. DOI ScienceOn |
15 | Garcea G, Dennison AR, Pattenden CJ, et al (2008). Survival following curative resection for pancreatic ductal adenocarcinoma. A systematic review of the literature. JOP, 9, 99-132. |
16 | Higgins JPT, Green S (2010) Cochrane Handbook for Systematic Reviews of Interventions. 5.0. |
17 | Jamieson NB, Denley SM, Logue J, et al (2011). A prospective comparison of the prognosticvalue of tumor- and patientrelated factors in patients undergoing potentially curative surgery for pancreatic ductal adenocarcinoma. Ann Surg Oncol, 18, 2318-28. DOI ScienceOn |
18 | Jamieson NB, Mohamed M, Oien KA, et al (2012). The relationship between tumor inflammatory cell infiltrate and outcome in patients with pancreatic ductal adenocarcinoma. Ann Surg Oncol, 19, 3581-90. DOI ScienceOn |
19 | Kayahara M, Nakagawara H, Kitagawa H, Ohta T (2007). The nature of neural invasion by pancreatic cancer. Pancreas, 35, 218-23 DOI ScienceOn |
20 | Kanda M, Fujii T, Sahin TT, et al (2010). Invasion of the splenic artery is a crucial prognostic factor in carcinoma of the body and tail of the pancreas. Ann Surg, 251, 483-7. DOI ScienceOn |
21 | Kanehara (1996) Japan Pancreas Society. The Classification of Pancreatic Carcinoma, the 1st English edition. Tokyo. |
22 | Kanehara (2003). Japan Pancreas Society: Classification of Pancreatic Carcinoma, 2nd edt. Tokyo. |
23 | Kato K, Yamada S, Sugimoto H, et al (2009).Prognostic factors for survival after extended pancreatectomy for pancreatic head cancer: influence of resection margin status on survival. Pancreas, 38, 605-12. DOI ScienceOn |
24 | Kayahara M, Nagakawa T, Konishi I, et al (1991). Clinicopathologic study of pancreatic carcinoma with particular reference to the invasion of the extrapancreatic neural plexus. Int J Pancreatol, 10, 105-11 |
25 | Kazanjian KK, Hines OJ, Duffy JP, et al (2008). Improved survival following pancreaticoduodenectomy to treat adenocarcinoma of the pancreas: the influence of operative blood loss. Arch Surg, 143, 1166-71. DOI ScienceOn |
26 | Kim J, Reber HA, Dry SM, et al (2006). Unfavourable prognosis associated with K-ras gene mutation in pancreatic cancer surgical margins. Gut, 55, 1598-1605. DOI ScienceOn |
27 | Kim R, Tan A, Lai KK, et al (2011). Prognostic roles of human equilibrative transporter 1 (hENT-1) and ribonucleoside reductase subunit M1 (RRM1) in resected pancreatic cancer. Cancer, 117, 3126-34. DOI ScienceOn |
28 | Koide N, Yamada T, Shibata R, et al (2006). Establishment of perineural invasion models and analysis of gene expression revealed an invariant chain (CD74) as a possible molecule involved in perineural invasion in pancreatic cancer. Clin Cancer Res, 12, 2419-26. DOI ScienceOn |
29 | Kneuertz PJ, Patel SH, Chu CK, et al (2011). Effects of perioperative red blood cell transfusion on disease recurrence and survival after pancreaticoduodenectomy for ductal adenocarcinoma. Ann Surg Oncol, 18, 1327-34. DOI |
30 | Maithel SK, Coban I, Kneuertz PJ, et al (2011.) Differential expression of ERCC1 in pancreas adenocarcinoma: high tumor expression is associated with earlier recurrence and shortened survival after resection. Ann Surg Oncol, 18, 2699-705. DOI ScienceOn |
31 | Lee SH, Kim H, Hwang JH, et al (2012). Breast cancer resistance protein expression is associated with early recurrence and decreased survival in resectable pancreatic cancer patients. Pathol Int, 62, 167-75. DOI ScienceOn |
32 | Liebig C, Ayala G, Wilks JA, Berger DH, Albo D (2009). Perineural invasion in cancer:a review of the literature. Cancer, 115, 3379-91. DOI ScienceOn |
33 | Mancuso A, Calabro F, Sternberg CN (2006). Current therapies and advances in the treatment of pancreatic cancer. Crit Rev Oncol Hematol, 58, 231-41. DOI ScienceOn |
34 | Mitsunaga S, Hasebe T, Kinoshita T, et al (2007). Detail histologic analysis of nerve plexus invasion in invasive ductal carcinoma and its prognostic impact. Am J Surg Pathol, 31, 1636-44. DOI ScienceOn |
35 | Mitsunaga S, Hasebe T, Iwasaki M, et al (2005). Important prognostic histological parameters for patients with invasive ductal carcinoma of the pancreas. Cancer Sci, 96, 858-65. DOI ScienceOn |
36 | Murakami Y, Uemura K, Sudo T, et al (2008). Postoperative adjuvant chemotherapy improves survival after surgical resection for pancreatic carcinoma. J Gastrointest Surg, 12, 534-41. DOI |
37 | Mollberg N, Rahbari NN, Koch M, et al (2011). Arterial resection during pancreatectomy for pancreatic cancer: a systematic review and meta-analysis. Ann Surg, 254, 882-93. DOI ScienceOn |
38 | Murakami Y, Uemura K, Sudo T, et al (2010).Prognostic impact of para-aortic lymph node metastasis in pancreatic ductal adenocarcinoma. World J Surg, 34, 1900-7. DOI |
39 | Nagakawa T, Kayahara M, Ohta T, et al (1991). Patterns of neural and plexus invasion of human pancreatic cancer and experimental cancer. Int J Pancreatol, 10, 113-9. |
40 | Murata Y, Hamada T, Kishiwada M, et al (2012). Human equilibrative nucleoside transporter 1 expression is a strong independent prognostic factor in UICC T3-T4 pancreatic cancer patients treated with preoperative gemcitabinebased chemoradiotherapy. J Hepatobiliary Pancreat Sci, 19, 413-25. DOI ScienceOn |
41 | Nagai K, Doi R, Katagiri F, et al S (2009).Prognostic value of metastin expression in human pancreatic cancer. J Exp Clin Cancer Res, 21, 28:9. |
42 | Nagakawa T, Kayahara M, Ueno K, et al (1992a). A clinicopathologic study on neural invasion in cancer of the pancreatic head. Cancer, 69, 930-5. DOI |
43 | Nagakawa T, Kayahara M, Ueno K, et al (1992b). Clinicopathologic study on neural invasion to the extrapancreatic nerve plexus in pancreatic cancer. Hepatogastroenterology, 39, 51-5. |
44 | Nakagohri T, Kinoshita T, Konishi M, Takahashi S, Gotohda N (2006). Nodal involvement is strongest predictor of poor survival in patients with invasive adenocarcinoma of the head of the pancreas. Hepatogastroenterology, 53, 447-51. |
45 | Pawlik TM, Gleisner AL, Cameron JL, et al (2007). Prognostic relevance of lymph node ratio following pancreaticoduodenectomy for pancreatic cancer. Surgery, 141, 610-8. DOI ScienceOn |
46 | Nimura Y (2002). Extended surgery in bilio-pancreatic cancer. The Japanese experience. Semin Oncol, 29, 17-22. DOI |
47 | Regine WF, Abrams RA (2006). Adjuvant therapy for pancreatic cancer: current status, future directions. Semin Oncol, 33, S10-13. DOI ScienceOn |
48 | Ozaki H, Hiraoka T, Mizumoto R, et al (1999). The prognostic significance of lymph node metastasis and intrapancreatic perineural invasion in pancreatic cancer after curative resection. Surg Today, 29, 16-22. DOI |
49 | Pour PM, Bell RH, Batra SK (2003). Neural invasion in the staging of pancreatic cancer. Pancreas, 26, 322-5. DOI ScienceOn |
50 | Ren F, Xu YC, Wang HX, Tang L, Ma Y (2012). Adjuvant chemotherapy, with or without postoperative radiotherapy, for resectable advanced pancreatic adenocarcinoma: continue or stop? Pancreatology, 12, 162-9. DOI ScienceOn |
51 | Sahin IH, Shama MA, Tanaka M, et al (2012).. Association of diabetes and perineural invasion in pancreatic cancer. Cancer Med, 1, 357-62. DOI |
52 | Schiffman SC, Chu CK, Park J, et al (2011). Is prior cholecystectomy associated with decreased survival in patients with resectable pancreatic adenocarcinoma following pancreaticoduodenectomy? Am J Surg, 201, 519-24. DOI ScienceOn |
53 | Sergeant G, Ectors N, Fieuws S, Aerts R, Topal B (2009). Prognostic relevance of extracapsular lymph node involvement in pancreatic ductal adenocarcinoma. Ann Surg Oncol, 16, 3070-9. DOI |
54 | Sobin LH, Wittekind C (2002). International Union Against Cancer.TNM Classification of MalignantTumours, 6th edn. New York: Wiley. |
55 | Shimada K, Nara S, Esaki M, et al (2011). Intrapancreatic nerve invasion as a predictor for recurrence after pancreaticoduodenectomy in patients with invasive ductal carcinoma of the pancreas. Pancreas, 40, 464-8. DOI ScienceOn |
56 | Squadroni M, Fazio N(2010). Chemotherapy in pancreatic adenocarcinoma. Eur Rev Med Pharmacol Sci, 14, 386-94. |
57 | Singal AK, Ross WA, Guturu P, et al (2011). Self-expanding metal stents for biliary drainage in patients with respectable pancreatic cancer: single-center experience with 79 cases. Dig Dis Sci, 56, 3678-84. DOI ScienceOn |
58 | Sperti C, Pasquali C, Piccoli A, Pedrazzoli S (1997). Recurrence after resection for ductal adenocarcinoma of the pancreas. World J Surg, 21, 195-200. DOI |
59 | Stocken DD, Büchler MW, Dervenis C, et al (2005). Metaanalysis of randomised adjuvant therapy trials for pancreatic cancer. Br J Cancer, 92, 1372-81. DOI ScienceOn |
60 | Stolinski C (1995). Structure and composition of the outer connective tissue sheaths of peripheral nerve. J Anat, 186, 123-30. |
61 | Takahashi H, Ohigashi H, Ishikawa O, et al (2012). Perineural invasion and lymph node involvement as indicators of surgical outcome and pattern of recurrence in the setting of preoperative gemcitabine-based chemoradiation therapy for resectable pancreatic cancer. Ann Surg, 255, 95-102. DOI ScienceOn |
62 | Turrini O, Paye F, Bachellier P, et al (2013). Pancreatectomy for adenocarcinoma in elderly patients: postoperative outcomes and long term results: a study of the French Surgical Association. Eur J Surg Oncol, 39, 171-8. DOI ScienceOn |
63 | Winter JM, Cameron JL, Campbell KA, et al (2006). 1423 pancreaticoduodenectomies for pancreatic cancer: A singleinstitution experience. J Gastrointest Surg, 10, 1199-210; discussion 1210-1. DOI ScienceOn |
64 | Watanabe T, Morinaga S, Akaike M, et al (2012). The cellular level of histone H3 lysine 4 dimethylation correlates with response to adjuvant gemcitabine in Japanese pancreatic cancer patients treated with surgery. Eur J Surg Oncol, 38, 1051-7. DOI ScienceOn |
65 | Xie H, Lin J, Thomas DG, Jiang W, Liu X (2012). Ribonucleotide reductase M2 does not predict survival in patients with resectable pancreatic adenocarcinoma. Int J Clin Exp Pathol, 5, 347-55. |
66 | Waters JA, Schnelldorfer T, Aguilar-Saavedra JR, et al (2011). Survival after resection for invasive intraductal papillary mucinous neoplasm and for pancreatic adenocarcinoma: a multi-institutional comparison according to American Joint Committee on Cancer Stage. J Am Coll Surg, 213, 275-83. DOI ScienceOn |
67 | Xie H, Jiang W, Xiao SY, Liu X (2013). High expression of survivin is prognostic of shorter survival but not predictive of adjuvant gemcitabine benefit in patients with resected pancreatic adenocarcinoma. J Histochem Cytochem, 61, 148-55. DOI |
68 | Nakao A, Harada A, Nonami T, Kaneko T, Takagi H(1996). Clinical significance of carcinoma invasion of the extrapancreatic nerve plexus in pancreatic cancer. Pancreas, 12, 357-61. DOI |
![]() |